Topic: United States
WASHINGTON (Reuters) - Aqua Bounty Technologies Inc's genetically engineered salmon are as safe to eat as normal Atlantic salmon, U.S. regulators said in a preliminary analysis released on Friday. The fish, called AquAdvantage, are genetically altered to grow twice as fast as ...
NEW YORK (Reuters) - A former hedge fund manager has been accused by a U.S. regulator of illegal insider trading in MedImmune Inc securities prior to the acquisition of the pharmaceutical company by Britain's AstraZeneca Plc. In a lawsuit filed Wednesday in ...
A Chinese researcher has been arrested and charged with stealing trade secrets about insecticides from US biotech company Dow and passing them on to China, court documents showed Tuesday. Huang Kexue, 45, was a researcher at Dow AgroSciences, a subsidiary of Dow ...
STOCKHOLM (Reuters) - AstraZeneca's new blood-thinning drug Brilinta has been given a class 1 recommendation as a treatment option under European medical guidelines, even though it has yet to be approved for sale. New European Society of Cardiology guidelines include the medicine, ...
Pharmaceutical training is essential for medical device businesses, pharmaceutical companies and nutraceutical organisations that play a huge role in our everyday lives. They carry out an important role in providing the world's national health services with quality products that can enable them ...
Corrects name of virus in 5th paragraph. LONDON (Reuters) - British pharmaceutical giant GlaxoSmithKline said on Monday it had started final trials of its new vaccine to prevent shingles, one of the most significant products in its pipeline. More than 30,000 patients ...
WASHINGTON (Reuters) - U.S. health officials on Monday proposed withdrawing approval of a Shire Plc hypotension drug because the company failed to conduct post-approval studies. The drug, ProAmatine, was approved in 1996 to treat orthostatic hypotension, a type of low blood pressure. ...
Judge revokes government's approval of genetically altered sugar beets until further reviewA federal judge has revoked the government's approval of genetically altered sugar beets until regulators complete a more thorough review of how the scientifically engineered crops affect organic food. Friday's ruling ...
NEW YORK (Reuters Health) - When drugmakers fund studies of their own products, the results are much more likely to be positive than when the government picks up the bill, US researchers said Monday. They found that about 85 percent of industry-backed ...
NEW YORK (Reuters) - Shares of Pfizer Inc rose 3.2 percent to $15.97 in premarket trading on Tuesday after the company reported its second-quarter results. (Reporting by Ryan Vlastelica, Editing by W Simon ) 81043790&bid=informcom" /> Copyright 2010  Reuters US Online Report ...